Heres What You Need to Know
This could potentially help these patients maintain or even increase their weight loss. Previous research on weight regain after GLP-1 receptor agonist discontinuation is mixed
Inflammation by itself is not the only factor in joint pain, but it may affect how pressure and movement are perceived
The Stanford Fe-Fi-Fo Lesson: Diversity Matters You might wonder: If I just eat a ton of fiber tomorrow, will I be a GLP-1 machine
"These findings may inform shared decision making when considering GLP- 1 receptor agonist therapy and highlight the need for further evaluation of dermatological outcomes in future studies." The study involved a large number of people: 12,004 patients using GLP-1 drugs were compared to 15,221 using SGLT-2 inhibitors, with an additional 11,964 GLP-1 users compared to 11,233 using DPP-4 inhibitors
While about 3,000 cases are already pending in the consolidated gastrointestinal litigation before Judge Karen S
